Aarey Drugs & Pharmaceuticals Limited share price
NSE: AAREYDRUGS · ISIN INE198H01019
Key numbers
- Market cap
- ₹ 339 Cr
- Current price
- ₹ 101.57
- 52-week high / low
- ₹ 104 / 50
- Stock P/E
- 79.4
- Book value
- ₹ 52.9
- Dividend yield
- 0.00%
- ROCE
- 5.4%
- ROE
- 2.7%
- Debt to equity
- 0.33
- Sales growth (3 yrs)
- 4.5%
- Profit growth (3 yrs)
- 1.7%
- 1-year return
- 30.9%
About Aarey Drugs & Pharmaceuticals Limited
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil. It also provides active pharmaceutical ingredients, such as metformin HCl, mefenamic acid, and doxofylline. In addition, the company trades chemicals and solvents, including aromatic chemicals, chemical acids, chlor-alkali, glycols and glycol ethers, fiber intermediates, and acetates and esters, as well as industrial alcohols, ketones, amines, oleochemicals, intermediates, olefins, phosphates, fertilizers, monomers, and chemicals. It serves pharmaceutical formulation manufacturers and pharmaceutical merchant exporters. Aarey Drugs & Pharmaceuticals Limited was incorporated in 1990 and is headquartered in Mumbai, India.
Quarterly results
Consolidated figures in ₹ crores
| Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|
| Sales | 102 | 84 | 96 | 189 | 45 |
| Operating profit | 2 | 3 | -2 | 4 | 1 |
| Net profit | 1 | 1 | 1 | 2 | 1 |
| EPS (₹) | 0.48 | 0.36 | 0.20 | 0.55 | 0.36 |
Peers in Drug Manufacturers - Specialty & Generic
Data for information only, not investment advice. Prices end of day.